Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Sales | 12,087,000 | 11,853,000 | 10,864,000 | 13,118,000 | 12,361,000 |
Cost of Goods | 2,219,000 | 2,180,000 | 1,838,000 | 2,702,000 | 2,368,000 |
Gross Profit | 9,868,000 | 9,673,000 | 9,026,000 | 10,416,000 | 9,993,000 |
Operating Expenses | 6,510,000 | 6,078,000 | 5,989,000 | 8,269,000 | 6,311,000 |
Operating Income | 3,358,000 | 3,595,000 | 3,037,000 | 2,147,000 | 3,682,000 |
Other Income | -661,000 | -56,000 | 45,000 | -344,000 | -95,000 |
Pre-tax Income | 2,697,000 | 3,539,000 | 3,082,000 | 1,803,000 | 3,587,000 |
Income Tax | 567,000 | 905,000 | 706,000 | 545,000 | 911,000 |
Net Income Continuous | 2,130,000 | 2,635,000 | 2,376,000 | 1,257,000 | 2,676,000 |
Net Income Discontinuous | 8,000 | 1,000 | 5,000 | -22,000 | -3,000 |
Minority Interests | 9,000 | 9,000 | 6,000 | 8,000 | 6,000 |
Net Income | $2,130,000 | $2,626,000 | $2,375,000 | $1,229,000 | $2,666,000 |
EPS Basic Total Ops | 0.35 | 0.43 | 0.38 | 0.20 | 0.42 |
EPS Basic Continuous Ops | 0.34 | 0.43 | 0.38 | 0.20 | 0.42 |
EPS Diluted Total Ops | 0.34 | 0.42 | 0.38 | 0.19 | 0.42 |
EPS Diluted Continuous Ops | 0.34 | 0.42 | 0.38 | 0.19 | 0.42 |
EBITDA(a) | $4,630,000 | $4,796,000 | $4,297,000 | $3,478,000 | $5,008,000 |